Tianyou Zhang1,2, Baojun Wang1,2, Jinfeng Zhang1,2, Na Ta3, Meng Fu1,2, Fan Hua Tian1,2, Jie Wang1,2. 1. Department of Neurology, Baotou Central Hospital, Baotou, Inner Mongolia, People's Republic of China. 2. Cerebrovascular Disease Research Institute of Inner Mongolia Autonomous Region, Baotou, Inner Mongolia, People's Republic of China. 3. Practical Teaching Skills Center, Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, People's Republic of China.
Abstract
PURPOSE: To compare the MRI characteristics of patients with wake-up ischemic stroke (WUS) and with ischemic stroke with known onset time (clear-onset-time stroke, COS) to clarify the role of diffusion-weighted imaging-fluid-attenuated inversion recovery (DWI-FLAIR) mismatch in estimating the onset time of WUS patients. PATIENTS AND METHODS: Two hundred patients with acute ischemic stroke were selected for complete brain MRI within six hours of symptom onset, including DWI and FLAIR sequences. The patients were divided into WUS (n = 78) and COS (n = 122) groups, based on whether the time of onset was known. The general conditions and imaging characteristics were collected to compare the DWI-FLAIR mismatch features between the two groups at different time intervals. RESULTS: There was no significant difference in the DWI-FLAIR mismatch on MRI within 2 hour after the first found abnormality between the two groups (50.0% vs 71.8%, p = 0.180). With increasing time, the DWI-FLAIR mismatch decreased substantially in the WUS group, while a higher DWI-FLAIR mismatch presence persisted in the COS group within a four-hour interval from the onset of symptoms to the MRI. The DWI-FLAIR mismatch was significantly lower in the WUS group than in the COS group from symptom identification to MRI at 2-3 h, 3-4 h, and 4-5 h intervals (15% vs 60%, 10.5% vs 48%, 6.7% vs 45.4%; p < 0.01). CONCLUSION: Our results suggest that the presence of DWI-FLAIR mismatch within 2 h of the first found abnormality was not significantly different between WUS and COS. Therefore, Patients with WUS within 2 hours after the first detected abnormality may be suitable for intravenous thrombolysis.
PURPOSE: To compare the MRI characteristics of patients with wake-up ischemic stroke (WUS) and with ischemic stroke with known onset time (clear-onset-time stroke, COS) to clarify the role of diffusion-weighted imaging-fluid-attenuated inversion recovery (DWI-FLAIR) mismatch in estimating the onset time of WUS patients. PATIENTS AND METHODS: Two hundred patients with acute ischemic stroke were selected for complete brain MRI within six hours of symptom onset, including DWI and FLAIR sequences. The patients were divided into WUS (n = 78) and COS (n = 122) groups, based on whether the time of onset was known. The general conditions and imaging characteristics were collected to compare the DWI-FLAIR mismatch features between the two groups at different time intervals. RESULTS: There was no significant difference in the DWI-FLAIR mismatch on MRI within 2 hour after the first found abnormality between the two groups (50.0% vs 71.8%, p = 0.180). With increasing time, the DWI-FLAIR mismatch decreased substantially in the WUS group, while a higher DWI-FLAIR mismatch presence persisted in the COS group within a four-hour interval from the onset of symptoms to the MRI. The DWI-FLAIR mismatch was significantly lower in the WUS group than in the COS group from symptom identification to MRI at 2-3 h, 3-4 h, and 4-5 h intervals (15% vs 60%, 10.5% vs 48%, 6.7% vs 45.4%; p < 0.01). CONCLUSION: Our results suggest that the presence of DWI-FLAIR mismatch within 2 h of the first found abnormality was not significantly different between WUS and COS. Therefore, Patients with WUS within 2 hours after the first detected abnormality may be suitable for intravenous thrombolysis.
Authors: Kennedy R Lees; Erich Bluhmki; Rüdiger von Kummer; Thomas G Brott; Danilo Toni; James C Grotta; Gregory W Albers; Markku Kaste; John R Marler; Scott A Hamilton; Barbara C Tilley; Stephen M Davis; Geoffrey A Donnan; Werner Hacke; Kathryn Allen; Jochen Mau; Dieter Meier; Gregory del Zoppo; D A De Silva; K S Butcher; M W Parsons; P A Barber; C Levi; C Bladin; G Byrnes Journal: Lancet Date: 2010-05-15 Impact factor: 79.321
Authors: Götz Thomalla; Bastian Cheng; Martin Ebinger; Qing Hao; Thomas Tourdias; Ona Wu; Jong S Kim; Lorenz Breuer; Oliver C Singer; Steven Warach; Soren Christensen; Andras Treszl; Nils D Forkert; Ivana Galinovic; Michael Rosenkranz; Tobias Engelhorn; Martin Köhrmann; Matthias Endres; Dong-Wha Kang; Vincent Dousset; A Gregory Sorensen; David S Liebeskind; Jochen B Fiebach; Jens Fiehler; Christian Gerloff Journal: Lancet Neurol Date: 2011-10-04 Impact factor: 44.182
Authors: Gisele S Silva; Fabricio O Lima; Erica C S Camargo; Wade S Smith; Aneesh B Singhal; David M Greer; Hakan Ay; Michael H Lev; Gordon J Harris; Elkan F Halpern; Shruti Sonni; Walter Koroshetz; Karen L Furie Journal: Cerebrovasc Dis Date: 2010-01-30 Impact factor: 2.762
Authors: Nishant K Mishra; Gregory W Albers; Stephen M Davis; Geoffrey A Donnan; Anthony J Furlan; Werner Hacke; Kennedy R Lees Journal: Stroke Date: 2009-11-19 Impact factor: 7.914
Authors: Martin Ebinger; Ivana Galinovic; Michal Rozanski; Peter Brunecker; Matthias Endres; Jochen B Fiebach Journal: Stroke Date: 2009-12-24 Impact factor: 7.914